Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety of Herceptin in Metastatic Breast Cancer

NCT02424682 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02424682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02424682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety of Herceptin in Metastatic Breast Cancer
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
August 31, 2007
Completion date
May 31, 2009
Enrollment
69 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, metastatic breast cancer